| CKPT Stock | | | USD 4.28 0.18 4.39% |
Checkpoint Therapeutics financial indicator trend analysis is way more than just evaluating Checkpoint Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Checkpoint Therapeutics is a good investment. Please check the relationship between Checkpoint Therapeutics Income Before Tax and its Cost Of Revenue accounts. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Checkpoint Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in american community survey.
For more information on how to buy Checkpoint Stock please use our
How to Invest in Checkpoint Therapeutics guide.
Income Before Tax vs Cost Of Revenue
Income Before Tax vs Cost Of Revenue Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Checkpoint Therapeutics Income Before Tax account and
Cost Of Revenue. At this time, the significance of the direction appears to have pay attention.
The correlation between Checkpoint Therapeutics' Income Before Tax and Cost Of Revenue is -0.97. Overlapping area represents the amount of variation of Income Before Tax that can explain the historical movement of Cost Of Revenue in the same time period over historical financial statements of Checkpoint Therapeutics, assuming nothing else is changed. The correlation between historical values of Checkpoint Therapeutics' Income Before Tax and Cost Of Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Income Before Tax of Checkpoint Therapeutics are associated (or correlated) with its Cost Of Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cost Of Revenue has no effect on the direction of Income Before Tax i.e., Checkpoint Therapeutics' Income Before Tax and Cost Of Revenue go up and down completely randomly.
Correlation Coefficient | -0.97 |
| Relationship Direction | Negative |
| Relationship Strength | Significant |
Income Before Tax
Income Before Tax which can also be referred as pre-tax income is reported on Checkpoint Therapeutics income statement and is an important metric when analyzing Checkpoint Therapeutics profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.
Cost Of Revenue
Cost of Revenue is found on Checkpoint Therapeutics income statement and represents the costs associated with goods and services Checkpoint Therapeutics provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.
Most indicators from Checkpoint Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Checkpoint Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Checkpoint Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in american community survey.
For more information on how to buy Checkpoint Stock please use our
How to Invest in Checkpoint Therapeutics guide.
Sales General And Administrative To Revenue is likely to gain to 88.54 in 2024, whereas
Selling General Administrative is likely to drop slightly above 7.3
M in 2024.
Checkpoint Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Checkpoint Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Checkpoint Therapeutics fundamental ratios Accounts
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Checkpoint Stock Analysis
When running Checkpoint Therapeutics' price analysis, check to
measure Checkpoint Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Checkpoint Therapeutics is operating at the current time. Most of Checkpoint Therapeutics' value examination focuses on studying past and present price action to
predict the probability of Checkpoint Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Checkpoint Therapeutics' price. Additionally, you may evaluate how the addition of Checkpoint Therapeutics to your portfolios can decrease your overall portfolio volatility.